Evidence map›Paper›PMID 36394090›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Digital Decoding of Single Extracellular Vesicle Phenotype Differentiates Early Malignant and Benign Lung Lesions.

Junrong Li, Abu A I Sina, Fiach Antaw, David Fielding, Andreas Möller, Richard Lobb, Alain Wuethrich, Matt Trau

Open access · goldAbstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Junrong LiCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0002-3777-2245
Abu A I SinaCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0001-8099-3863
Fiach AntawCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0002-2895-3298
David FieldingDepartment of Thoracic Medicine, Royal Brisbane and Women's Hospital, Herston, QLD, 4029, Australia.ORCID https://orcid.org/0000-0003-2311-4919
Andreas MöllerTumour Microenvironment Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, 4006, Australia.ORCID https://orcid.org/0000-0002-8618-6998
Richard LobbCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0001-9548-8843
Alain WuethrichCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0001-9569-0478
Matt TrauCentre for Personalised Nanomedicine, Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, QLD, 4072, Australia.ORCID https://orcid.org/0000-0001-5516-1280
The University of Queensland · AUQIMR Berghofer Medical Research Institute · AURoyal Brisbane and Women's Hospital · AU

Funding

Australian Research Council DE200100345Australian Research Council DP210103151Cancer Australia AppID_2010799Commonwealth Scientific and Industrial Research OrganizationNational Breast Cancer Foundation of Australia CG-12-07National Health and Medical Research Council APP1173669National Health and Medical Research Council APP1175047National Health and Medical Research Council APP1185907
6 · The paper itself

Abstract

Accurate identification of malignant lung lesions is a prerequisite for rational clinical management to reduce morbidity and mortality of lung cancer. However, classification of lung nodules into malignant and benign cases is difficult as they show similar features in computer tomography and sometimes positron emission tomography imaging, making invasive tissue biopsies necessary. To address the challenges in evaluating indeterminate nodules, the authors investigate the molecular profiles of small extracellular vesicles (sEVs) in differentiating malignant and benign lung nodules via a liquid biopsy-based approach. Aiming to characterize phenotypes between malignant and benign groups, they develop a single-molecule-resolution-digital-sEV-counting-detection (DECODE) chip that interrogates three lung-cancer-associated sEV biomarkers and a generic sEV biomarker to create sEV molecular profiles. DECODE capturessEVs on a nanostructured pillar chip, confines individual sEVs, and profiles sEV biomarker expression through surface-enhanced Raman scattering barcodes. The author utilize DECODE to generate a digitally acquired sEV molecular profiles in a cohort of 33 people, including patients with malignant and benign lung nodules, and healthy individuals. Significantly, DECODE reveals sEV-specific molecular profiles that allow the separation of malignant from benign (area under the curve, AUC = 0.85), which is promising for non-invasive characterisation of lung nodules found in lung cancer screening and warrants further clinincal validaiton with larger cohorts.

Indexed as

lung cancer screeningplasmonic nanostructuressmall extracellular vesiclessurface-enhanced Raman scattering

Identifiers

PMID36394090
PMCPMC9811438
OpenAlexW4309245063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.